Bioxcel Therptcs Rg

BioXcel Therapeutics leverages AI to develop advanced neuro‑ and immune‑oncology drugs, with 3+ candidates in late‑stage trials and strategic collaborations with Yale, Columbia and VA. Positioning for high‑impact market growth in neurology and oncology.

Headquarters: United States (USA)

Bioxcel Therptcs Rg Logo
Company Profile
  • Employees: 37
  • HQ: New Haven
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
BTAI Bioxcel Therptcs Rg
Cap: 0.0B
EQUITY NCM USD US09075P1057 Active
📈
Home Login